Concentra Group Holdings Parent, Inc. (CON) is a Healthcare stock trading at $34.77 (as of 2026-08-25), with a market capitalization of $4.43B and a trailing P/E of 20.7. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.
Concentra Group Holdings Parent, Inc. provides occupational health services in the United States. The company offers occupational and consumer health services, including workers' compensation injury care, urgent care, clinical testing, preventative care, and employer services, as well as wellness programs through occupational health centers and onsite clinics. It also provides Concentra Telemed, a telemedicine solution for the treatment of work-related injuries and illnesses, and employer services; pharmacy solution under the Concentra Pharmacy name; and Concentra Medical Compliance Administration, a third-party administrator that helps to manage abuse testing programs for employers with regulated or non-regulated workforces. The company was founded in 1979 and is based in Mechanicsburg, Pennsylvania. Concentra Group Holdings Parent, Inc. operates as a subsidiary of Select Medical Corporation.
Concentra provides occupational health services (workers' comp injury care, urgent care, clinical testing, wellness programs) to US employers, billing per-visit fees and employer service contracts. Most revenue comes from per-visit workers' comp claims across its center network, with a growing on-site clinic segment embedded in employer premises.
Revenue scales linearly with visit volume: each workers' comp visit generates roughly $213 in fee-for-service income, so the profit engine is adding visits across centers and on-site sites, not raising per-visit prices.
| Workers' Comp | $0.3B |
| Employer Services | $0.2B |
| On-Site Clinics | $0.0B |
| Consumer Health | $0.0B |
| Other | $0.0B |
Business quality (Solid): Solid recurring-fee business with 19% operating margin and 44% ROE, underpinned by a large sticky employer customer base and minimal cyclical exposure.
Valuation: At 21× earnings, CON trades 18% below the Healthcare Services average (25×).
| Price | $34.77 |
| Market Cap | $4.43B |
| P/E Ratio | 20.7 |
| EV / EBITDA | 8.9 |
| Price / Book | 9.15 |
| Price / Sales | 1.91 |
| FCF Yield | 5.6% |
| DCF Value (model) | $38.41 |
| DCF Upside vs Price | 10.5% |
| Revenue (TTM) | $2.16B |
| Net Margin | 7.7% |
| Revenue Growth (YoY) | 15.9% |
| EPS Growth (YoY) | 70.6% |
| FCF Growth (YoY) | 134.8% |
| Altman Z-Score | 2.33 (grey) |
| Stock P/E | 20.7 |
| Sector P/E (Healthcare) | 21.9 |
| Industry P/E (Healthcare Services) | 25.4 |
| vs Sector | -5.8% |
| vs Industry | -18.7% |
| Top Institutional Holder | BlackRock, Inc. ($366.09M) |
| Institutional Holders Tracked | 10 |
| Congressional Trades (recent) | 2 |
| Sector | Healthcare |
| Industry | Healthcare Services |
| CEO | William Keith Newton |
| Employees | 8,758 |
| Country | US |
| IPO Date | 2010-05-25 |
Data as of 2026-08-25.
Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.